SG Americas Securities
NVO

SG Americas Securities’s Novo Nordisk NVO Stock Holding History

SG Americas Securities’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,212,500
Closed -$2.3M – 3559
2025
Q4 		$2.3M Sell
2,212,500
-100,000
-4% -$5.11M ﹤0.01% 1445
2025
Q3 		$5.27M Buy
+2,312,500
New +$135M 0.02% 493

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

SG Americas Securities's NVO Position: Q1 2026 in Review

SG Americas Securities reduced its Novo Nordisk (NVO) stake by 81% in Q1 2026, selling an estimated $97.8M and leaving 472,124 shares worth $17.4M. The position accounts for 0.02% of the portfolio, ranked #597.

SG Americas Securities first reported a position in NVO in Q1 2015 and has held it in 33 quarters since. The position peaked at $132M in Q3 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • SG Americas Securities held 472,124 shares of Novo Nordisk worth $17.4M as of Q1 2026.
  • SG Americas Securities sold 2,063,222 Novo Nordisk shares in Q1 2026, an estimated $97.8M.
  • Novo Nordisk made up 0.02% of SG Americas Securities's portfolio in Q1 2026, its #597 holding.
  • SG Americas Securities first reported a position in Novo Nordisk in Q1 2015 and has held it in 33 quarters since.
  • SG Americas Securities's Novo Nordisk position peaked at $132M in Q3 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.